Adline Chem Lab posts Rs 4.75 lakh September-half loss
Key highlights
- Adline Chem Lab reported a Rs 4.75 lakh total comprehensive loss for the half year ended September 30, 2026.
- Negative other equity reached Rs 7.67 crore at September 30, 2026, compared with Rs 7.62 crore at March 31, 2026.
- Operating activities used Rs 2.64 lakh of cash, while financing activities generated Rs 3.56 lakh in the September 2026 half year.
- Non-current borrowings were Rs 1.89 crore at September 30, 2026, up from Rs 1.80 crore at March 31, 2026.
powered by IRIS

Adline Chem Lab Limited posted a Rs 4.75 lakh total comprehensive loss for the half year ended September 30, 2026, taking negative other equity to Rs 7.67 crore and leaving operating activities with a Rs 2.64 lakh cash outflow. The company’s equity share capital stood at Rs 5.85 crore at September 30, 2026.
Know Adline Chem Lab inside out
Results, valuation, peers and who's buying, in one view.
How did Adline Chem Lab perform in the September 2026 half year?
Adline Chem Lab recorded a Rs 4.75 lakh total comprehensive loss for the half year ended September 30, 2026. The standalone unaudited statement reported a Rs 4.67 lakh loss before tax and Rs 0.07 lakh of other comprehensive income, resulting in the stated half-year comprehensive loss.
The September 2026 quarter also reported a Rs 0.75 lakh total comprehensive loss, after the filing showed Rs 4.00 lakh of total comprehensive income for the quarter ended June 30, 2026. The two quarterly outcomes did not produce a positive first-half result, with the reported half-year loss standing at Rs 4.75 lakh.
Basic and diluted earnings per share for continuing operations were a loss of Rs 0.08 for the half year ended September 30, 2026. Adline Chem Lab said the earnings-per-share figures were not annualised for the September 2026 quarter, June 2026 quarter, September 2025 quarter, or the half years ended September 2026 and September 2025.
What does Adline Chem Lab’s September balance sheet show?
Adline Chem Lab reported total assets of Rs 11.31 lakh at September 30, 2026, compared with Rs 6.91 lakh at March 31, 2026. Cash and cash equivalents rose to Rs 7.47 lakh from Rs 6.55 lakh, while other current assets increased to Rs 3.84 lakh from Rs 0.37 lakh.
Adline Chem Lab’s negative other equity widened to Rs 7.67 crore at September 30, 2026, from Rs 7.62 crore at March 31, 2026. Equity share capital was unchanged at Rs 5.85 crore, meaning negative other equity exceeded that share-capital amount by Rs 1.82 crore at the September balance-sheet date.
Non-current borrowings were Rs 1.89 crore at September 30, 2026, up from Rs 1.80 crore at March 31, 2026. Deferred tax liabilities rose to Rs 2.41 lakh from Rs 2.34 lakh, while other financial liabilities fell to Rs 0.47 lakh from Rs 1.01 lakh and other current liabilities increased to Rs 1.14 lakh from Rs 0.73 lakh.
How did Adline Chem Lab’s operating cash flow change?
Adline Chem Lab used Rs 2.64 lakh in operating activities in the half year ended September 30, 2026, compared with Rs 15.83 lakh used in the half year ended March 31, 2026. The current-period outflow followed a Rs 4.67 lakh loss before tax, partly offset by Rs 5.65 lakh of interest expense in the cash-flow reconciliation.
Operating profit before working-capital changes was Rs 0.97 lakh for the September 2026 half year, against a loss of Rs 17.44 lakh in the half year ended March 31, 2026. A Rs 3.48 lakh increase in other current assets and a Rs 0.14 lakh decrease in other current liabilities led to the Rs 2.64 lakh operating cash outflow.
Adline Chem Lab reported no cash flow from investing activities for the September 2026 half year. Financing activities generated Rs 3.56 lakh, reflecting a Rs 9.21 lakh increase in borrowings partly offset by Rs 5.65 lakh of interest expense, and cash and cash equivalents consequently rose by Rs 0.92 lakh to Rs 7.47 lakh.
Got a follow-up? Ask IRIS
How do the borrowing figures compare across Adline Chem Lab’s statements?
Adline Chem Lab’s cash-flow statement shows a Rs 9.21 lakh increase in borrowings for the half year ended September 30, 2026. Its balance sheet shows non-current borrowings increasing by Rs 9.22 lakh, from Rs 1.80 crore at March 31, 2026 to Rs 1.89 crore at September 30, 2026.
The Rs 0.01 lakh difference between the cash-flow movement and the balance-sheet movement is not explained in the filing. Both presentations nevertheless show borrowings higher at September 30, 2026, while the company reported a Rs 2.64 lakh operating cash outflow over the same half-year period.
The filing also records Rs 5.65 lakh of interest expense in both the operating-cash-flow reconciliation and financing cash flows for the half year ended September 30, 2026. No repayment timetable, capital-raising plan or borrowing terms were disclosed alongside the Rs 1.89 crore non-current borrowing balance.
What did Adline Chem Lab’s auditor and board say about the results?
Adline Chem Lab’s statutory auditor, Jain Kedia & Sharma, issued an unmodified limited-review conclusion on the standalone unaudited results for the quarter and half year ended September 30, 2026. In its report dated November 5, 2026, the auditor said nothing had come to its attention suggesting the results were not prepared, in all material respects, under applicable Indian Accounting Standards.
The auditor said it conducted the engagement under Standard on Review Engagements 2400 (Revised), which involves mainly inquiries and analytical procedures rather than a full audit. The report states that this review provides less assurance than an audit, although it identified no material misstatement in the September 2026 results.
Adline Chem Lab’s board approved and took the standalone unaudited financial results on record on November 5, 2026. The board meeting began at 5:10 p.m. and concluded at 5:40 p.m., and the company said the results were prepared under Indian Accounting Standards.
Conclusion
Adline Chem Lab’s September 2026 half-year filing combines a Rs 4.75 lakh comprehensive loss, Rs 7.67 crore of negative other equity and a Rs 2.64 lakh operating cash outflow. Cash increased by Rs 0.92 lakh to Rs 7.47 lakh, but financing activities generated Rs 3.56 lakh and non-current borrowings rose to Rs 1.89 crore.
The next disclosure can be assessed for any clarification of the Rs 0.01 lakh difference between the reported borrowing movement in cash flow and the balance-sheet change. The filing does not disclose a capital plan, repayment schedule, target or forecast, leaving the September 2026 borrowing balance and future operating cash flow as reported matters to monitor.


